Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. Its lead product candidate includes AlloNK, an...
Leadership
Fred Aslan M.D.
CEO, Principal Financial & Accounting Officer and Director
Gines Diego Miralles M.D.
President and Head of Research & Development
Jennifer Kinsbruner Bush Esq., J.D.
Chief Operating Officer
Christopher P. Horan
Chief Technical Operations Officer
Peter Flynn Ph.D.Founder
Co-Founder & Strategic Advisor
Andrew Cronauer
VP, General Counsel & Corporate Secretary
Nicholas Veomett Ph.D.
Vice President of Corporate Development
Heather Raymon Ph.D.
Senior Vice President of Research & Early Development
